| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11010972 | Clinical Biochemistry | 2018 | 27 Pages |
Abstract
These dysregulated metabolites in sera of HCC patients potentially could be used as biomarkers for the clinical staging of HCC.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Wenjuan Wang, Junxia Lv, Nan Chen, Bin Lou, Weilin Mao, Peipei Wang, Yu Chen,